stella
beta
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection — Stella
Home
/
Newly Diagnosed
/
View on ClinicalTrials.gov
Recruiting
Back to Newly Diagnosed trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu